{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:06:00Z","timestamp":1792181160280,"version":"4.4.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":4774,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004755","name":"EMD Serono","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004755","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","fertstert.org","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.fertnstert.2008.02.009","type":"journal-article","created":{"date-parts":[[2008,4,4]],"date-time":"2008-04-04T15:31:33Z","timestamp":1207323093000},"page":"1755-1759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Premature luteinization and in vitro fertilization outcome in gonadotropin\/gonadotropin-releasing hormone antagonist cycles in women with polycystic ovary syndrome"],"prefix":"10.1016","volume":"91","author":[{"given":"Shimon","family":"Segal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Glatstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"McShane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selen","family":"Hotamisligil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Ezcurra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2008.02.009_bib1","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0015-0282(16)55933-0","article-title":"Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer","volume":"59","author":"Fanchin","year":"1993","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.009_bib2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0015-0282(16)53945-4","article-title":"Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome","volume":"54","author":"Edelstein","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.009_bib3","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0015-0282(97)00337-3","article-title":"Consequences of premature progesterone elevation of the outcome of in vitro fertilization: insights into a controversy","volume":"68","author":"Fanchin","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.009_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0015-0282(16)58453-2","article-title":"Premature luteinization in vitro fertilization cycles using gonadotropin releasing hormone agonist (GnRH-a) and recombinant follicle stimulating hormone (FSH) and GnRH-a and urinary FSH","volume":"66","author":"Ubaldi","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.009_bib5","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0015-0282(16)58693-2","article-title":"Premature luteinization during controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer has no impact on pregnancy outcome","volume":"66","author":"Hofmann","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.009_bib6","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0015-0282(16)57857-1","article-title":"Physiopathology of premature progesterone elevation","volume":"64","author":"Fanchin","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.009_bib7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/humrep\/14.3.601","article-title":"Elevated serum progesterone on the day of HCG administration in IVF is associated with a higher pregnancy rate in polycystic ovary syndrome","volume":"14","author":"Doldi","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.02.009_bib8","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/BF02065939","article-title":"Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antagonist Cetrorelix at different dosages","volume":"13","author":"Felberbaum","year":"1996","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2008.02.009_bib9","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/oxfordjournals.humrep.a019409","article-title":"Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist cetrorelix in intracytoplasmic sperm injection cycles","volume":"11","author":"Ubaldi","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.02.009_bib10","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.fertnstert.2003.07.002","article-title":"Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome","volume":"80","author":"Bosch","year":"2003","journal-title":"Fertil Steril"},{"issue":"Suppl 1","key":"10.1016\/j.fertnstert.2008.02.009_bib11","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1016\/S0015-0282(02)03779-2","article-title":"Progesterone elevation during GnRH antagonist cycles in IVF adversely affects pregnancy and implantation rates","volume":"78","author":"Valencia","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.009_bib12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0015-0282(02)03782-2","article-title":"Polycystic ovarian syndrome (PCOS) patients have a favorable response to ganirelex acetate during controlled ovarian hyperstimulation (COH) for in vitro fertilization (IVF)-embryo transfer (ET)","volume":"S1","author":"Bracero","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.009_bib13","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0015-0282(02)04696-4","article-title":"Concurrent ganirelix and follitropin beta therapy is an effective and safe regimen for ovulation induction in women with polycystic ovarian syndrome","volume":"79","author":"Elkind-Hirsch","year":"2003","journal-title":"Fertil Steril"},{"issue":"Suppl 1","key":"10.1016\/j.fertnstert.2008.02.009_bib14","first-page":"S25","article-title":"GnRH antagonists for treatment of polycystic ovarian syndrome","volume":"80:","author":"Cardone","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.009_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"2004 revised consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.009_bib16","series-title":"Immulite 2000, Operator's manual, document number 690149, revision F, version 4xx, 1\u20133","author":"Diagnostic Products Corporation","year":"2005"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028208002501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028208002501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T18:40:32Z","timestamp":1737398432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028208002501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0015028208002501"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2008.02.009","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Premature luteinization and in vitro fertilization outcome in gonadotropin\/gonadotropin-releasing hormone antagonist cycles in women with polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2008.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}